Phosphatidylinositol 4,5 bisphosphate (PIP 2 ) is a key lipid messenger for regulation of cell migration. PIP 2 modulates many effectors, but the specificity of PIP 2 signalling can be defined by interactions of PIP 2 -generating enzymes with PIP 2 effectors. Here, we show that type Ic phosphatidylinositol 4-phosphate 5-kinase (PIPKIc) interacts with the cytoskeleton regulator, IQGAP1, and modulates IQGAP1 function in migration. We reveal that PIPKIc is required for IQGAP1 recruitment to the leading edge membrane in response to integrin or growth factor receptor activation. Moreover, IQGAP1 is a PIP 2 effector that directly binds PIP 2 through a polybasic motif and PIP 2 binding activates IQGAP1, facilitating actin polymerization. IQGAP1 mutants that lack PIPKIc or PIP 2 binding lose the ability to control directional cell migration. Collectively, these data reveal a synergy between PIPKIc and IQGAP1 in the control of cell migration. The EMBO Journal advance online publication, 27 August 2013; doi:10.1038/emboj.2013 Subject Categories: cell & tissue architecture; membranes & transport Keywords: cell migration; IQGAP1; PIP 2 ; PIPKIg; polybasic motif
Introduction
Cell migration is a highly orchestrated, multistep process requiring the establishment of polarity, the regulation of cytoskeleton dynamics and spatiotemporal signalling Parsons et al, 2010) . Cell migration is initiated in response to extracellular stimuli, such as cytokines and signals from the extracellular matrix (ECM). These extracellular signals activate intracellular signalling cascades that promote changes in the cytoskeleton. A diverse array of proteins are implicated in these processes, but scaffold proteins that integrate signals from multiple structural and signalling molecules play pivotal roles in transmitting cellular information (Rodriguez et al, 2003; Good et al, 2011) . Previous work has focussed on how scaffold proteins coordinate different signals. However, the exact mechanism of how scaffold proteins themselves are targeted and activated remains largely unknown.
IQ motif containing GTPase activating protein 1 (IQGAP1) is a multidomain protein that regulates cytoskeletal dynamics, proliferation, adherens junction integrity and vesicular trafficking, by serving as a scaffold for key signals (Brown and Sacks, 2006; Brandt and Grosse, 2007; Osman, 2010) . IQGAP1 targets to the leading edge, where it promotes actin polymerization through Rac1 and Cdc42 and their effectors, such as N-WASP and Dia1 (Ho et al, 1999; Li et al, 1999; Brown and Sacks, 2006; Brandt et al, 2007; Le Clainche et al, 2007) . IQGAP1 also controls microtubule (MT) behaviour. IQGAP1 interacts with MT plus end regulators, CLIP-170 and adenomatous polyposis coli (APC), and recruits MTs to the leading edge membrane (Fukata et al, 2002; Watanabe et al, 2004) . By targeting MTs to the leading edge, IQGAP1 is believed to facilitate the polarized trafficking of protein to the migrating front Osman, 2010 ). Yet, how IQGAP1 interacts with the leading edge membrane is largely undefined. A recent study has shown that phosphatidylinositol 4,5 bisphosphate (PIP 2 )-dependent microdomains are required for the recruitment of MTs to the plasma membrane (PM), and Cdc42, N-WASP and IQGAP1 are also required in this process (Golub and Caroni, 2005) . However, the exact role for PIP 2 in IQGAP1 regulation of the cytoskeleton at the PM is unknown.
At a molecular level, IQGAP1 is kept inactive through an autoinhibitory interaction between the GRD domain and RGCT domain (Brandt and Grosse, 2007) . This autoinhibition can be relieved by RhoGTPase binding to the GRD domain or phosphorylation on Ser1443 to activate IQGAP1 (Grohmanova et al, 2004; Li et al, 2005) . In agreement with this model of activation, a mutant IQGAP1, defective in RhoGTPase binding on the GRD domain, induces multiple leading edges (Fukata et al, 2002) and a phosphomimetic variant of IQGAP1 on Ser1443 stimulates neurite outgrowth (Li et al, 2005) .
PIP 2 comprises B1% of membrane phospholipids and is the most abundant phosphoinositide species at the PM. Besides serving as a precursor for other lipid messengers, PIP 2 exerts direct signalling roles by interacting with protein targets (Anderson et al, 1999; Heck et al, 2007) . Though PIP 2 binding is often achieved by defined modules on proteins, including C2, pleckstrin homology (PH) and band 4.1/ezrin/ radixin/moesin (FERM) domains, many PIP 2 -interacting proteins lack canonical modules and instead contain clusters of basic amino acids, known as polybasic motifs (PBMs) that bind PIP 2 (McLaughlin et al, 2002) . The interaction of PBMs with phosphoinositides is largely mediated by the positively charged residues in the PBM that interact with the phosphate head group. Therefore, these interactions in some cases can be promiscuous for phosphoinositides (McLaughlin and Murray, 2005) . Recent advances in proteomic analyses have identified hundreds of putative PIP 2 binding proteins, but most of them do not contain canonical modules (Catimel et al, 2008; Dixon et al, 2011) , and thus many PBMs or atypical phosphoinositide binding motifs remain to be characterized.
PIP 2 modulates the activity and targeting of cytoskeleton regulatory proteins, controlling cytoskeletal dynamics and, ultimately, migration (Yin and Janmey, 2003; Zhang et al, 2012) . Although the roles for PIP 2 in cytoskeleton regulation are extensively studied, the roles for PIP 2 -generating enzymes in this process are still emerging (Ling et al, 2006; Zhang et al, 2012) . In mammalian cells, PIP 2 is primarily generated by type I PIP kinases (PIPKIs), and three isoforms, a, b and g, are expressed in humans with multiple isoforms (van den Bout and Divecha, 2009 ). For example, four different isoforms of PIPKIg are expressed in humans and each displays unique cellular distribution. PIPKIgi1 is the most abundant isoform in most cell types and largely locates to the PM (Mao and Yin, 2007) . PIPKIgi2 is found at focal adhesions and cell-cell contacts (Ling et al, 2002 . PIPKIgi4 is found largely in the nucleus, while PIPKIgi5 localizes to cell-cell contacts and intracellular compartments (Schill and Anderson, 2009 ). Often, protein-protein interactions recruit PIPKI isoforms to specific cellular regions, and many of these targeting proteins are themselves PIP 2 effectors (Anderson et al, 1999; Heck et al, 2007) . For example, talin recruits PIPKIgi2 to focal adhesions, while the site-specific generation of PIP 2 by PIPKIgi2 strengthens talin binding to b1-integrin (Ling et al, 2006) .
PIPKIg and IQGAP1 are implicated in cancer progression and metastasis (Johnson et al, 2009; Sun et al, 2010) . Overexpression of PIPKIg in breast cancer was found to correlate with poor prognosis (Sun et al, 2010) . Loss of the PIPKIgi2 isoform from metastatic breast cancer cell lines reduces cell motility (Thapa et al, 2012) , but the role of other PIPKIg isoforms and molecular mechanisms remain elusive. Similarly, loss of IQGAP1 from malignant breast epithelial cells reduces cell motility (Mataraza et al, 2003) and cell growth (Jadeski et al, 2008) . IQGAP1 overexpression is reported in cancers originating from many different tissues (White et al, 2009) . IQGAP1 is shown to regulate the function of many oncoproteins. Notably, IQGAP1 is found at the invasive front of aggressive cancers (Johnson et al, 2009) without knowing the underlying mechanism.
Here, we report IQGAP1 as a novel PIP 2 effector that is tightly regulated by PIP 2 -generating enzyme PIPKIg. PIPKIg and IQGAP1 interact and function together in regulation of directional cell migration. Mechanistically, IQGAP1 requires PIPKIg for targeting to the leading edge membrane of migrating cells. Also, IQGAP1 is activated specifically by PIP 2 , disrupting IQGAP1 autoinhibition to induce actin polymerization. Directional cell migration is dramatically attenuated in cells expressing IQGAP1 mutants that lack PIPKIg or PIP 2 interaction. Given that expression of both proteins is deregulated in cancers, this study identifies the PIPKIg/IQGAP1 signalling nexus as a putative therapeutic target in the early steps of cancer progression.
Results

IQGAP1 and PIPKIc interact
Interacting proteins often determine the function and intracellular targeting of PIPKIs (Heck et al, 2007) . To identify interacting proteins for PIPKIg, i1 and i5 isoforms were inducibly expressed and immunoprecipitated (IP'ed) from MDCK cell lysates. The isolated complexes were separated by SDS-PAGE and the gels visualized by Coomassie staining. Then, protein bands were analysed by mass spectrometry. IQGAP1 was identified to interact with the PIPKIgi1 and i5 complexes ( Figure 1A) .
The interaction between PIPKIg and IQGAP1 was confirmed in human cell lines. Endogenous proteins were IP'ed and association was examined by immunoblotting. IQGAP1 co-IP'ed with PIPKIg, and vice versa, from HEK 293 and MDA-MB-231 cell lysates ( Figure 1B ). The cellular location of the proteins was examined via immunostaining. DsRedPIPKIgi1 colocalized with endogenous IQGAP1 at the periphery of MCF7 cells and to a lesser extent at a perinuclear compartment ( Figure 1C ). To characterize binding, HisPIPKIgi1 and GST-IQGAP1 were expressed in E. coli, purified and in vitro binding was assessed. As shown in Figure 1D , the binding was saturable and Scatchard analysis revealed that the dissociation constant (K d ) for the interaction is B175 nM, demonstrating that in vitro PIPKIg directly interacts with IQGAP1 with a moderate affinity.
PIPKIc interacts with the IQ domain
IQGAP1 integrates many signalling pathways by forming interactions through its calponin homology (CHD), WW, IQ, GAP-related (GRD) and RasGAP C-terminal (RGCT) domains (Brown and Sacks, 2006) . To identify the PIPKIg binding site on IQGAP1, we coexpressed Myc-IQGAP1 wild type (WT) or deletion mutants of each domain with HA-PIPKIgi1 in HEK 293 cells and performed an IP. Deletion of the IQ domain (DIQ) abrogated IQGAP1 co-IP with PIPKIg ( Figure 1E ), and in vitro the DIQ mutant also failed to interact with PIPKIg ( Figure 1F) . Furthermore, the IQ domain alone was capable of interacting with IQGAP1 ( Figure 1F and Supplementary Figure S2A ). These data indicate that the IQ domain is both necessary and sufficient to interact with PIPKIg.
The IQ domain is composed of four tandem IQ motifs. The CaM À mutant, which contains point mutations in the IQ motifs and abrogates calmodulin binding (Li and Sacks, 2003) , bound PIPKIg to a lesser extent than WT ( Figure 1F ). Furthermore, deletion or mutation of individual motifs reduced binding to PIPKIg, compared to WT, and the combined mutation of multiple IQ motifs further reduced binding ( Figure 1F ; and S Choi, unpublished observations). These data indicate that the intact IQ domain is required for the interaction with PIPKIg. Further studies used the DIQ mutant to examine the functional importance of the PIPKIg interaction.
Migration and lamellipodium formation require PIPKIc
A role for PIPKIgi2 in migration is emerging Thapa et al, 2012) . To further define a role of other PIPKIg isoforms in the regulation of migration, we stably knocked down PIPKIg in MDA-MB-231 cells using two different shRNAs (Thapa et al, 2012) . ShRNA 1 and 2 reduced total PIPKIg (panPIPKIg) expression by B75 and 90%, respectively. PIPKIgi2 expression was also slightly reduced (B24 and 36%, respectively), whereas i4 and i5 expression were not changed (Supplementary Figure S1B) , as reported previously (Wang et al, 2004) . These data indicate that PIPKIgi1 is the predominant isoform in these cells (Mao and Yin, 2007) . By bright field microscopy, PIPKIg knockdown cells were less spread than control cells with fewer protrusions (Supplementary Figure S1A) . Seruminduced migration using a Transwell assay was significantly attenuated by PIPKIg knockdown (Supplementary Figure  S1B) . These data indicate that PIPKIg is required for proper spreading and migration.
Knockdown of PIPKIgi2 has a defined migration defect Thapa et al, 2012) , but PIPKIgi1 could not be knocked down specifically as it is a splice variant with no unique coding sequence compared to the other isoforms. To explore the role of PIPKIgi1 and i2, we separately re-expressed these two isoforms to determine if they restore migration. The shRNA-resistant DsRed-PIPKIg was stably re-expressed in PIPKIg knockdown cells. Cells were then sorted to isolate cells with expression levels similar to endogenous PIPKIg in control cells. Re-expression of PIPKIgi2 rescued migration (Supplementary Figure S1C) , as (kD) Figure 1 PIPKIg interacts with the IQ motif of IQGAP1. (A) HA-PIPKIgi1 and i5 were expressed in tet-off MDCK cells, and an anti-HA antibody used to IP i1-and i5-containing complexes. Samples were resolved by SDS-PAGE and protein bands visualized by Coomassie staining. Dox, doxycycline. (B) PIPKIg and IQGAP1 were separately IP'ed and association of the other protein examined by immunoblotting. IgG, isotype immunoglobulin control. (C) DsRed-PIPKIgi1 was transiently expressed in MCF-7 cells and endogenous IQGAP1 was immunostained. Cells were photographed under Â 600 magnification. (D) GST-IQGAP1 (50 pM) was incubated with 5 to 1600 nM His-PIPKIgi1. Binding was detected by immunoblotting with an anti-His antibody (top). K d was determined by standard Scatchard analysis (bottom). (E) Myc-IQGAP1 proteins were coexpressed with HA-PIPKIgi1 in HEK293 cells and proteins were IP'ed with an anti-Myc antibody. Associated PIPKIgi1 was analysed by immunoblotting with an anti-HA antibody. (F) Purified GST-IQGAP1 proteins were incubated with His-PIPKIgi1. The associated protein complex was examined by immunoblotting with the indicated antibodies. Some degraded products of GST-IQGAP1 proteins were detected by immunoblotting with an anti-GST antibody. Data above are representative of at least four independent experiments. (G) Schematic representation of IQGAP1 domains and IQGAP1 constructs used for this study. Source data for this figure is available on the online supplementary information page.
PIPKIc regulates IQGAP1 function in cell migration S Choi et al reported previously (Thapa et al, 2012) . Interestingly, PIPKIgi1 WT also rescued the migration whereas i1 kinase dead (KD) did not rescue, indicating that PIPKIgi1 or i2 are sufficient for serum-induced migration, and PIP 2 synthesis is required for this process. Migrating cells extend lamellipodia at the leading edge and persistent formation of lamellipodia is critical for directional migration (Ridley, 2011) . To test how PIPKIg regulates lamellipodium formation, a lamellipodial marker ARPC2 (Le Clainche et al, 2007) was immunostained following initiation of migration by scratch-wounding confluent cells. At 3 h after scratching, ARPC2 localized at the periphery of protrusions in the control cells (Supplementary Figure S1D) . In PIPKIg knockdown cells, formation of protrusions was retarded and ARPC2 no longer localized at the membrane extensions. PIPKIgi1 or i2 re-expression could recover lamellipodium formation, whereas PIPKIgi1 KD had no effect. Early protrusion formation was indistinguishable in different cells but persistent formation was diminished (Supplementary Figure S1E ). This demonstrates that PIPKIg, by generation of PIP 2 , regulates persistent lamellipodium formation that is required for migration.
PIPKIc and IQGAP1 interdependently control cell motility
Upon stimulation, IQGAP1 targets to the leading edge and recruits regulators of the cytoskeleton that control migration Brown and Sacks, 2006) . As described above, PIPKIg also regulates migration (Thapa et al, 2012) . Pip5k1c, a gene coding PIPKIg in mice, knockout (KO) mice are embryonic lethal with migration defects of cardiovascular cell precursors (Wang et al, 2007) , and cells from these mice have a defective association between the membrane and the cytoskeleton (Wang et al, 2008) . To investigate how PIPKIg and IQGAP1 control cell motility, serum-induced cell motility was measured using a Transwell system. Individual knockdown of PIPKIg or IQGAP1 significantly reduced both migration and invasion ( Figure 2A ). Knockdown of both proteins dramatically reduced cell motility, indicating a synergistic role. To better define the relationship of the two proteins, we overexpressed IQGAP1 that is reported to enhance cell motility (Mataraza et al, 2003) . Overexpression of IQGAP1 in MDA-MB-231 cells increased cell motility over three-fold, whereas knockdown of PIPKIg in IQGAP1 overexpressing cells reduced cell motility to the basal level. Consistently overexpression of PIPKIgi1 increased cell motility and this increase was inhibited by knockdown of IQGAP1 ( Figure 2B ). Similar results were obtained in HeLa cells. Here, inducible expression of PIPKIgi1 increased cell motility and depletion of IQGAP1 under these conditions returned motility to the basal level ( Figure 2C ). Together these data indicate that PIPKIg and IQGAP1 interdependently control cell motility.
The PIPKIc-IQGAP1 interaction is required for migration To investigate how PIPKIg and IQGAP1 function together, we tested if their association is altered by stimuli that promote migration. Migration is initiated by a variety of extracellular stimuli, including chemokines or ECM . To define the pathway in which PIPKIg and IQGAP1 function, cells were stimulated with type I collagen (COL) or serum and changes in the association were examined by IP. In response to either stimulus there was an increase in the panPIPKIg-IQGAP1 complex, whereas the Rac1 interaction with IQGAP1 remained unchanged ( Figure 2D ). This demonstrates that the PIPKIg interaction with IQGAP1 is enhanced by factors that stimulate migration. Furthermore, phosphorylation of Ser1441 and Ser1443 residues of IQGAP1 (Grohmanova et al, 2004; Li et al, 2005) is required to enhance the interaction (Supplementary Figure S2C) . Interestingly, the PIPKIgi2 interaction was unaffected, suggesting that migration enhances IQGAP1 interaction with the predominant isoform, PIPKIgi1 (Mao and Yin, 2007) . This is consistent with results indicating that PIPKIgi2 modulates cell migration by a different mechanism Thapa et al, 2012) .
The IQGAP1 mutant that lacks interaction with PIPKIg (DIQ) was examined to determine if this interaction is required for migration. For this, Iqgap1 KO mouse embryonic fibroblasts (MEFs) (Ren et al, 2007) were reconstituted with WT or DIQ IQGAP1 and migration was examined under various conditions (Keely, 2001 ). To avoid nonspecific effects from overexpression, we maintained IQGAP1 expression levels similar to the WT MEFs by the cell sorting method as above (Supplementary Figure S1 ). Iqgap1 KO MEFs showed 450% reduction in migration in response to serum, fibronectin or epidermal growth factor (EGF) stimuli. WT IQGAP1 fully rescued migration under all of these conditions, while the DIQ mutant showed no recovery of migration induced by fibronectin or EGF ( Figure 2E ). This indicates that the PIPKIg-IQGAP1 interaction is necessary for integrin-and EGF receptor-mediated migration. Intriguingly, the DIQ mutant still rescued serum-induced migration. Serum contains a collection of factors that induce migration and the contribution of each factor in PIPKIgregulated migration varies by cell types . Collectively, the PIPKIg-IQGAP1 interaction specifically regulates fibronectin-or EGF-induced migration in MEFs (Supplementary Figure S2D) , indicating that the PIPKIg-IQGAP1 nexus is regulated by these pathways.
PIPKIc controls IQGAP1 translocation to the leading edge membrane
At the onset of migration, many cytoskeleton regulatory proteins translocate to the leading edge membrane to mediate directional migration (Del Pozo et al, 2002; Ling et al, 2006; Ridley, 2011) . To further define how PIPKIg and IQGAP1 regulate migration, we examined their targeting to the membrane by cell fractionation. Cells were plated on COL, then lysed and fractionated into membrane and cytosolic components (Chao et al, 2010) . In response to integrin activation, both PIPKIg and IQGAP1 increased in the membrane fraction ( Figure 3A ). Rac1 also increased in the membrane fraction, as reported previously (Del Pozo et al, 2002) . However, membrane proteins, such as calnexin, GM-130 and Na þ K þ channel, remained unchanged ( Figure 3A ).
In response to receptor activation, IQGAP1 translocates to the leading edge membrane (Brandt and Grosse, 2007; White et al, 2012 ). Yet, the mechanism for IQGAP1 interaction with the membrane is largely unknown. To examine if PIPKIg regulates IQGAP1 membrane targeting, PIPKIg was knocked down using RNAi and cells were fractionated. Knockdown of PIPKIg significantly reduced IQGAP1 in the membrane fraction upon COL and/or EGF stimulation ( Figure 3B ). The knockdown of PIPKIg also reduced the membrane content of Rac1, supporting reports that PIPKI and Rac1 interdependently control PM targeting (Chao et al, 2010; Halstead et al, 2010) . To test the contribution of PIPKIg in IQGAP1 targeting, we utilized a Rac1 binding defective mutant PIPKIg (E111L) (Halstead et al, 2010) . The mutant co-immunoprecipitated with IQGAP1 similar to WT PIPKIg (Supplementary Figure  S2E) , indicating that Rac1 binding to PIPKIg is not required for PIPKIg interaction with IQGAP1. Notably, the E111L mutant enhanced IQGAP1 association with the membrane fraction similar to WT PIPKIg (Supplementary Figure S2F) . These data suggest that the IQGAP1 recruitment to the leading edge is largely regulated by PIPKIg independent of Rac1. Knockdown of IQGAP1 reduced Rac1 in the membrane fraction, but had no effect on PIPKIg accumulation in the membrane fraction.
To assess targeting in vivo, serum-starved cells were treated with EGF to induce lamellipodia formation (Baumgartner et al, 2006) and IQGAP1 localization was observed by immunostaining. As shown in Figure 3C , the number of PIPKIg knockdown cells with IQGAP1-positive protrusions was reduced by 450% compared to the control cells. To assess PIPKIg regulation of IQGAP1 localization in migrating cells, endogenous IQGAP1 was immunostained in cells migrating into the scratch wound. IQGAP1 nicely localized at the leading edge in the control cells, but in PIPKIg knockdown cells the IQGAP1 staining at the cell periphery was PIPKIc regulates IQGAP1 function in cell migration S Choi et al significantly reduced ( Figure 3D ). Reconstitution with either PIPKIgi1 or i2 WT, but not i1 KD, rescued IQGAP1 localization at the leading edge. The difference between WT and KD is not due to an improper interaction with IQGAP1 because the amount of PIPKIgi1 KD that co-IP'ed with IQGAP1 was indistinguishable from that of WT (Supplementary Figure  S2B) . Taken together, these results demonstrate that PIPKIg and generation of PIP 2 are required for IQGAP1 targeting to the leading edge membrane in response to migratory signals. 
F s i p a n P I P K I γ s i p a n P I P K I γ s i l Q G A P 1 Figure 3 PIPKIg regulates IQGAP1 targeting to the leading edge membrane. (A) MDA-MB-231 cells maintained in suspension were plated on 10 ng/ml COL for the indicated times. Cells were lysed with a hypotonic buffer and the membrane fraction was separated from the cytosolic fraction by centrifugation. Then, 10 mg of each protein was resolved by SDS-PAGE and analysed by immunoblotting with the indicated antibodies (top). The percentage of protein bound in the pellet relative to total (S þ P) was calculated by quantifying the immunoblots (bottom). S, supernatant. P, pellet. (B) After transient knockdown with the indicated siRNA, cells were treated as in (A) in the presence or absence of 50 ng/ml EGF for 30 min. Cells were fractionated and analysed as above. (C) Serum-starved control or PIPKIg knockdown cells were treated with 20 ng/ml EGF for 1 h. Cells were fixed and stained for IQGAP1 and F-actin. Cells were photographed at Â 400 magnification. For quantification, at least 300 cells were counted. White arrowheads indicate IQGAP1-positive lamellipodia. Data are shown as mean ± s.d. of three independent experiments. (D) Cells grown to confluence were wounded and fixed 3 h later, followed by immunostaining for IQGAP1. Cells were photographed at Â 400 magnification. Intensity of fluorescent signal at the migrating front was measured from at least 10 different images of each condition and quantified using ImageJ software. Data are shown as mean±s.d. of three independent experiments. All the experiments described above were performed independently at least three times. Source data for this figure is available on the online supplementary information page. hypothesized that IQGAP1 could be a PIP 2 effector. Consistent with this hypothesis, two independent proteomic analyses suggest that IQGAP1 interacts with PIP 2 (Catimel et al, 2008; Dixon et al, 2011) . To understand how IQGAP1 interacts with PIP 2 , their cellular distributions were examined by immunostaining. PH domain from phospholipase Cd1 (PLCd1) has been extensively used to probe cellular PIP 2 (Czech, 2000; Di Paolo and De Camilli, 2006) but excessive expression prevents targeting of PIP 2 binding proteins to the plasma membrane . Thus, we titrated the GFP-PLCd1-PH expression and analysed endogenous IQGAP1 localization (Supplementary Figure S4B ). In the optimal amount of expression, endogenous IQGAP1 partially colocalized with GFP-PLCd1-PH ( Figure 4A and Supplementary Figure S4B ), indicating that both IQGAP1 and PIP 2 are present at regions of the PM containing PIP 2 . To define PIP 2 binding, liposomes were synthesized containing membrane lipids (57.5% of phosphatidylcholine, 20% of phosphatidylethanolamine and 20% of phosphatylserine in molar ratio) and 2.5% PI4,5P 2 . A cosedimentation assay was used to define the PIP 2 binding site on IQGAP1. IQGAP1-N or -C ( Figure 1G ) were examined and only IQGAP1-C co-sedimented with PIP 2 liposomes, indicating that PIP 2 binds to the C-terminal half ( Figure 4B ).
A lysine cluster mediates IQGAP1 interaction with PIP 2 IQGAP1 does not contain known PIP 2 binding modules, but we found at least two potential PBMs within AA 921-970 and 1491-1560, named PBM1 and PBM2, respectively ( Figure 1G ). Deletion of PBM2 dramatically reduced IQGAP1 interaction with PIP 2 liposomes, whereas deletion of PBM1 had little effect, indicating that IQGAP1 interacts with PIP 2 through PBM2 ( Figure 4C ). To define a putative PIP 2 binding site on PBM2, human IQGAP1, 2 and 3 sequences were aligned with (kD) -100 P I P I 3 P P I 4 P P I 5 P P I 3 , 4 P 2 P I 3 , 5 P 2 P I 4 , 5 P 2 P I 3 , 4 , 5 P 3
HS IQGAP1 NQRRYRQRRKAELVKLQQTYAALNSKATFYGEQVDYYKSYIKTCLDNLASK--GKVSKKPREMKGKKS-----------KKIS HS IQGAP2 NQRIYRKLRKAELAKLQQTLNALNKKAAFYEEQINYYDTYIKTCLDNLKRKNTRRSIKLDGKGEPKGA-----------KRAK HS IQGAP3 NQHRHRHRRKAELVKLQATLQGLSTKTTFYEEQGDYYSQYIRACLDHLAPD---------SKSSGKGK-----------KQPS Danio
NQRRYRQRRKAELVKLQQTNSGLNSKTKFYNEQIDYYNQYIKTCMDNLGSK--GKVSKKPGDKQAKKS-----------KQVS
Figure 4 IQGAP1 interacts with the phosphoinositides through a polybasic motif. (A) GFP-PLCd1-PH was transiently expressed in MDA-MB-231 cells and endogenous IQGAP1 was immunostained. Cells were photographed at Â 600 magnification. (B) PIP 2 liposomes (2.5%) were incubated with 0.5 mM GST-IQGAP1-N or -C for 10 min. Liposome-bound IQGAP1 was pelleted by centrifugation. Equal volume of the supernatant and the pellet were resolved by SDS-PAGE and IQGAP1 in each fraction was analysed by immunoblotting with an anti-GST antibody. (C) GST-tagged WT or deletion mutants were used for a sedimentation assay with 2.5% PIP 2 liposomes. (D) Amino acid sequence alignment of the PBM2 region among IQGAPs from the indicated species. (E) Selected lysine residues were mutated to alanines to generate a series of AA mutants (top). Binding of WT and the AA mutants to 5% PIP 2 liposomes were tested (bottom). (F) Binding of GST-tagged WT and the AA3 mutant to 5 mM of 5% phosphoinositide liposomes were tested. Samples were analysed as above and liposome-bound proteins were detected by immunoblotting with anti-GST antibody. Immunoblots were quantified and the graph is shown as mean ± s.d. of three independent experiments. All the experiments described above were performed independently at least four times. Source data for this figure is available on the online supplementary information page.
PIPKIc regulates IQGAP1 function in cell migration S Choi et al IQGAP sequences from multiple species. As shown in Figure 4D , the sequence alignment identified a lysine residue, marked by an asterisk, which is conserved in PBM2. Around this lysine, there are other conserved basic residues, highlighted in red. We mutated these residues to alanines as illustrated in Figure 4E and tested the impact on PIP 2 liposome binding. Mutating two or four lysine residues had little effect, whereas mutating all six residues (termed AA3) eliminated IQGAP1 binding to the PIP 2 liposomes. To examine phospholipid binding specificity, a lipid overlay assay was performed. IQGAP1 WT and -C bound to multiple phosphoinositides but not other phospholipids (Supplementary Figure S3A) . To better define IQGAP1 phosphoinositide binding, the IQGAP1-C fragment was used in liposome sedimentation assays, with liposomes containing 5% phosphoinositide (Papayannopoulos et al, 2005) . In this assay, PI3,4P 2 , PI3,5P 2 and PI3,4,5P 3 bound with a higher affinity than PI3P, PI4P, PI5P and PI4,5P 2 ( Figure 4F ). Although the apparent affinity for other bis-and tris-phosphate species is up to seven-fold higher than PI4,5P 2 , PI4,5P 2 is estimated to be present in the PM at a concentration 20-to 100-fold higher than other phosphoinositide species (Papayannopoulos et al, 2005) , indicating that PI4,5P 2 is the major in vivo ligand for IQGAP1. The AA3 mutation reduced binding to PI3,4P 2 , PI3,5P 2 and PI3,4,5P 3 but not monophosphate species ( Figure 4F) . Strikingly, the AA3 mutant lost binding to PI4,5P 2 . The combined data indicate that IQGAP1-C has multiple distinct phosphoinositide binding sites (Dixon et al, 2012) and the lysine cluster mutated in AA3 defines a specific PI4,5P 2 binding site.
The IQGAP1 PIP 2 binding mutant exhibited multiple leading edges and loss of migration To determine how PIP 2 binding modulates IQGAP1 function, the AA3 mutant was expressed in Iqgap1 KO MEFs and the cell morphology was examined. When plated on a stiff substratum (glass or plastic) coated with COL, fibronectin or gelatin, all types of cells indistinguishably highly spread and formed massive stress fibres (S Choi, unpublished observations). Cytoskeleton organization and cell shape are greatly influenced by substrate stiffness (Solon et al, 2007) , and therefore cells were plated on pliant gelatin gel and cell morphology was observed by staining F-actin. Three distinct cell morphologies were observed compared to the starshaped cells (type 1 morphology) that were predominant in WT MEFs ( Figure 5A ). Iqgap1 KO resulted in an increase in the number of cells with a single leading edge (type 2). Reconstitution of IQGAP1 WT partially recovered shapes of WT MEFs, whereas the DIQ mutant had a limited effect. Interestingly, the number of cells with multiple leading edges (type 3) was increased in the AA3-reconstituted cells ( Figure 5A ). To closely examine localization of the reconstituted proteins, IQGAP1 was immunostained. WT IQGAP1 localized at the leading edge where active actin polymerization occurs. The DIQ mutant was largely cytoplasmic and failed to localize at the leading edge ( Figure 5B, arrowhead) , supporting the results in Figure 3 indicating that the interaction with PIPKIg controls IQGAP1 targeting.
The AA3-reconstituted cells formed multiple leading edges and the AA3 mutant localized at these sites ( Figure 5B ). Consistent with this morphological phenotype, the AA3-reconstituted cells did not rescue haptotactic migration ( Figure 5C ). The functional defects of AA3 were not due to a change in interaction with PIPKIg as co-IP of the AA3 mutant with PIPKIg was indistinguishable from that of WT IQGAP1 (Supplementary Figure S3B and C) . Rather, the defects result from the loss of directional persistence ( Figure 5D , Supplementary Figure S4 and Supplementary Movies 1-3). This indicates that the IQGAP1 interaction with PIPKIg is required for IQGAP1 targeting to the leading edge, but PIP 2 binding is required for the role of IQGAP1 in normal membrane protrusions (lamellipodia formation) and migration.
IQGAP1-PIP 2 interaction regulates actin polymerization
Knockdown of PIPKIg reduced IQGAP1 targeting to the leading edge membrane. Also, in knockdown cells actin polymerization at the leading edge, indicated by strong F-actin staining, was lost and stress fibre formation was increased ( Figures 3C and 6A ), signifying that PIPKIg controls actin polymerization at the leading edge by regulating IQGAP1 targeting. However, the AA3 mutant is capable of interacting with PIPKIg and localizes at the leading edge membrane, but forms multiple leading edges ( Figure 5B ). These data suggest that PIPKIg regulates activity of IQGAP1 required for persistent formation of a single leading edge.
IQGAP1 folds into an inactive conformation through an intramolecular interaction between the GRD and the RGCT domains (Brandt and Grosse, 2007) . RhoGTPase binding to the GRD or phosphorylation of Ser1443 disrupts autoinhibition and activates IQGAP1 (Grohmanova et al, 2004) . We identified a PIP 2 binding PBM within the RGCT domain close to Ser1443, suggesting that PIP 2 binding to this PBM may open the inactive conformation (Brandt et al, 2007; Le Clainche et al, 2007) . To test this hypothesis, we examined how phosphoinositides affect binding between the GRD and the RGCT domains. For this analysis, His-C2 was incubated with immobilized GST-C1 ( Figure 1G ) in the presence or absence of phosphoinositide liposomes. In the absence of liposomes, C1 bound to C2 as reported previously (Grohmanova et al, 2004) . Intriguingly, the binding was dramatically decreased in the presence of PI4,5P 2 liposomes, while other phosphoinositides or phosphatidylinositol had no significant effect. Introduction of the AA3 mutation in the C2 fragment eliminated the effect of PI4,5P 2 on the C1-C2 binding ( Figure 6B and Supplementary Figure S5C) . Although the AA3 IQGAP1-C interacts with other phosphoinositide species, it lacks PI4,5P 2 binding ( Figure 4F ). This indicates that there are multiple phosphoinositide binding sites in IQGAP1-C (Dixon et al, 2012), but only PI4,5P 2 binding to the PBM modulates the activation of IQGAP1 as indicated by a loss of the C1-C2 interaction.
The C-terminal fragment of IQGAP1 (AA 746-1657) enhances actin polymerization by activating N-WASP (Le Clainche et al, 2007) . Using this system, the influence of phosphoinositides in IQGAP1-mediated actin polymerization was assessed. Since the actin polymerization activity of N-WASP is also regulated by PI4,5P 2 , a N-WASP-DB mutant, which lacks the PI4,5P 2 -responsive element (Rohatgi et al, 2000) , was used for this assay. Addition of PI4,5P 2 liposomes had no effect while addition of IQGAP1-C enhanced actin polymerization as shown previously (Le Clainche et al, 2007) . Introduction of PI4,5P 2 liposomes in combination with WT IQGAP1-C significantly enhanced actin polymerization 
Discussion
Here, we define a novel mechanism of how PIPKIg and IQGAP1 function together as a signalling nexus to regulate migration ( Figure 7) . In polarized epithelial cells, IQGAP1 is largely localized to cell-cell contacts (Li et al, 1999; Fukata et al, 2001; Watanabe et al, 2004; Noritake et al, 2005) . In directionally migrating cells, IQGAP1 translocates to the leading edge (Mataraza et al, 2003) and facilitates actin polymerization. In response to receptor signalling, PIPKIg associates with IQGAP1 and recruits IQGAP1 to the leading edge membrane. There, generation of PIP 2 by PIPKIg activates IQGAP1, as PIP 2 binding to a PBM relieves autoinhibition between the RGD and RGCT domains. This allows the RGCT domain to recruit N-WASP and the Arp2/3 complex to facilitate actin polymerization (Supplementary Figure S3E ) (Brandt and Grosse, 2007) . Overall, extracellular stimuli control the spatiotemporal activation of the PIPKIg/IQGAP1 nexus to regulate actin polymerization required for persistent formation of lamellipodia and migration.
All PIPKIg isoforms have the potential to interact with IQGAP1 ( Figure 1A ) and this suggests that IQGAP1 may mediate isoform-specific functions at different compartments. For example, IQGAP1 is found in the nucleus and ectopic expression of IQGAP1 enhances transcriptional activity of bcatenin (Briggs et al, 2002) . Similarly, PIPKIg also modulates b-catenin-mediated transcriptional co-activation (Schramp et al, 2011) . IQGAP1 associates with the exocyst complex and regulates cancer cell invasion, a function also regulated by PIPKIgi2 . Here, we demonstrate that receptor signalling stimulates the recruitment of IQGAP1 to the leading edge through an interaction with PIPKIg, likely the PIPKIgi1 isoform ( Figure 2D ). PIPKIgi2 isoform plays an analogous role by interaction with talin, linking the trafficking of integrin-containing vesicles to talin-rich adhesions (Thapa et al, 2012) .
Rel. haptotaxis Figure 2E . (D) Reconstituted MEFs were plated on gelatin gel for 3 h before recording using time-lapse microscopy. Images were collected every min for 6 h at Â 100 magnification and combined into a time-lapse movie. The migration path of six individual cells was then traced and plotted on a grid, with the origin of each cell placed in the centre of the grid. All the experiments described above were performed independently at least three times. Source data for this figure is available on the online supplementary information page.
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The C-terminal half of IQGAP1 (IQGAP1-C) binds to different phosphoinositide species with a varying binding affinity ( Figure 4F ). A recent study shows that the distal portion of the C-terminus of IQGAP1 (AA 1559-1657) forms a pseudo C2 domain fold and binds to class I phosphoinositide 3-kinase products, PI3,4P 2 and PI3,4,5P 3 (Dixon et al, 2012) . According to the solved structure, Lys1562 and Lys1604 are important for ligand recognition. Here we define a distinct PI4,5P 2 -binding site at Lys1546, Lys1547, Lys1554, Lys1555, Lys1557 and Lys1558 (Figure 4 ). These data indicate that there could be multiple phosphoinositide binding sites on IQGAP1-C. Consistent with this possibility, the IQGAP1-C1 interaction with IQGAP1-C2 is specifically inhibited by PI4,5P 2 , while mutating the six lysine residues blocks the inhibition ( Figure 6B ). Further work is necessary to define other phosphoinositide binding sites on IQGAP1. These studies will give us mechanistic insight into how IQGAP1 is found at the intracellular compartments where different phosphoinositide species are predominant (Di Paolo and De Camilli, 2006; Osman, 2010) .
PIPKIg regulates IQGAP1 targeting to the leading edge and this event requires PIP 2 generation (Figure 3) . IQGAP1 is widely believed to target to the PM by association with Rac1 and Cdc42 (Fukata et al, 2002; Watanabe et al, 2004; Brandt and Grosse, 2007) . Rac1 and Cdc42 contain PBMs near the C-termini and these PBMs contribute to membrane targeting (Del Pozo et al, 2002; Heo et al, 2006) . This raises the possibility that PIP 2 controls IQGAP1 targeting to the PM by indirectly regulating Rac1 targeting. Consistently, sequestration of cellular PIP 2 by either neomycin treatment (Gabev et al, 1989) or PLCd1-PH expression blocks both Rac1 and IQGAP1 translocation to membrane in response to integrin activation (Supplementary Figure S3D) . To examine the sole contribution of PIP 2 binding S T -N o n e W T -N o n e N o n e P I P I 3 P P I 4 P P I 5 P P I 3 , 4 P 2 P I 3 , 5 P 2 P I 4 , 5 P 2 P I 3 , 4 , 5 P 3 Figure 6 Phosphoinositide binding regulates IQGAP1 function in actin polymerization. (A) Control or PIPKIg knockdown MDA-MB-231 cells were grown on cover glass for 24 h. Cells were fixed and endogenous IQGAP1 and F-actin were stained. Cells were photographed at Â 600 magnification. (B) A total of 0.05 mM of His-C2 WT or AA3 mutant was incubated with 1 mM of GST-C1 immobilized on glutathione beads in the absence or presence of the indicated phosphoinositide liposomes (2 mM) for 10 min. Liposome-bound proteins were detected by immunoblotting with an anti-His antibody. Immunoblots were quantified and the graph is shown as mean±s.d. of three independent experiments. (C) Actin polymerization in the presence of the indicated combinations of GST-IQGAP1-C (50 nM) or 5% PI4,5P 2 liposomes (2 mM). The experiments described above were performed independently at least four times. Source data for this figure is available on the online supplementary information page.
PIPKIc regulates IQGAP1 function in cell migration S Choi et al for IQGAP1 targeting, we generated and expressed a PIP 2 -binding-defective mutant of IQGAP1 in Iqgap1 À / À MEFs.
The PIP 2 -binding-defective mutant still localizes to the PM, while the PIPKIg-binding-defective (DIQ) mutant is largely cytosolic ( Figure 5B ). These data indicate that the physical interaction between the two proteins is more important than PIP 2 binding for targeting IQGAP1 to the PM. Cells expressing the PIP 2 binding IQGAP1 mutant (AA3) form multiple leading edges, suggesting that PIP 2 regulation of IQGAP1 is important for maintaining polarity and leading edge integrity ( Figure 5B ). These cells exhibit perpetual formation and retraction of leading edges but display little movement ( Figure 5D and Supplementary Movie 3). Consistent with this observation, IQGAP1 is suggested to maintain polarity of migrating cells through local capture of MTs at the leading edge by interaction with MT regulators . The interaction sites for these proteins are within the RGCT domain, which also contains the PIP 2 binding site (Brown and Sacks, 2006) . We envision that the autoinhibitory interaction between the GRD and RGCT domains may also block MT recruitment, and PIP 2 binding may relieve this ( Figure 3A ). In this model, the AA3 mutant may remain inactive at the leading edge and fail to recruit MTs, which would result in loss of cell polarity. Alternatively, multiple leading edges could be induced by perturbation of actin dynamics. In support of this possibility, cells display multiple leading edges after manipulation of certain actin regulatory proteins. For example, multiple leading edges also form in Cdc42 KO dendritic cells (Lammermann et al, 2009) and in Vero cells after expression of an IQGAP1 mutant that is defective in Rac1/ Cdc42 binding (Fukata et al, 2002) . 
Materials and methods
Cell culture and constructs MDA-MB-231, HEK 293, MCF-7 and MEF cells were maintained in DMEM supplemented with 10% fetal bovine serum (Gibco). MDCK and HeLa tet-off cells were cultured as previously described and induction of transgene was achieved by removing of doxycycline from media for 24 h. The constructs used for this work have been described previously (Sokol et al, 2001; Li et al, 2005; Papayannopoulos et al, 2005; Le Clainche et al, 2007; Ren et al, 2007) .
Stable cell line generation
To generate stable MDA-MB-231 cell lines, cells were transfected with vectors expressing DsRed-PIPKIg isoforms using Lipofectamine 2000 (Invitrogen) and selected with 1.2 mg/ml Geneticin (Gibco) for 15 days, and further selected for DsRed expression using cell sorter. Cells expressing the transgene at a level similar to the endogenous level of PIPKIg were used for experiments. For generation of stable cell lines in MEFs, cells were infected with retrovirus for 24 h. Then, cells expressing GFP-IQGAP1 were first selected for GFP expression, and then further sorted by expression level.
Antibodies and siRNAs
Monoclonal antibodies against IQGAP1, b-tubulin, Myc-tag, Na þ K þ ATPase, GST-tag, His-tag (Millipore), a/b-tubulin, cyclin D1 (Cell Signaling Technology), Rac1, calnexin, GM-130 (BD Biosciences), HA-tag (Covence Biotechnology), actin (MP Biomedicals) and polyclonal antibody against IQGAP2 (Santa Cruz Biotechnology) were used for this study. Polyclonal and monoclonal antibodies against total and specific isoforms of PIPKIg were produced as described previously (Schill and Anderson, 2009) . Pooled siRNAs against PIPKIg were obtained from Dharmacon and IQGAP1 from Santa Cruz Biotechnology.
IP and immunoblotting
Cells were lysed in a buffer containing 1% Brij58, 150 mM NaCl, 20 mM HEPES, pH 7.4, 2 mM MgCl 2 , 2 mM CaCl 2 , 1 mM Na 3 VO 4 , 1 mM Na 2 MoO 4 and protease inhibitors. Protein concentration of lysates was measured by the BCA method (Pierce) and equal amounts of protein were used for further analysis. For IP, 0.5 to 1 mg of proteins were incubated with 1 mg of antibodies at 41C for 8 h and then incubated with a 50% slurry of Protein G Sepharose (GE Life Sciences) for another 2 h. After washing 5 Â with lysis buffer, the protein complex was eluted with SDS sample buffer. For immunoblotting, 10 to 20 mg of proteins were loaded. After developing immunoblots, the film was scanned using a transmitted light scanner (resolution ¼ 600 d.p.i.). Protein bands were quantified using ImageJ, and statistical analysis of the data was performed with Microsoft Excel. The statistical analysis was performed using data from at least three independent experiments.
In vitro binding assay
Recombinant proteins were expressed in BL21 E. coli strain. GSTtagged proteins were then purified with GST Sepharose 4B (GE Life Sciences) and His-tagged proteins were purified with His-Bind Resin (Novagen). GST-tagged proteins were incubated with glutathione beads before binding assays. The binding assay was performed in the lysis buffer used for IP by adding 10 nM to 5 mM of His-tagged proteins and 20 ml of GST-tagged protein bound to glutathione beads. After incubation for 1 h at 251C, unbound proteins were washed out and the protein complex was analysed by immunoblotting. For the binding assay with liposomes, analysis was performed for 10 m at 251C without detergent (150 mM KCl, 50 mM HEPES, pH 7.4, 2 mM MgCl 2 , 2 mM CaCl 2 and protease inhibitors) to maintain the integrity of liposomes.
Transwell motility assay
Motility assays were performed with a Transwell (Corning) as described before (Keely, 2001) . Briefly, equal numbers of cells were loaded on the upper chamber and cells that migrated towards attractants were fixed with 4% paraformaldehyde followed by Model of PIP 2 -mediated IQGAP1 activation. In response to receptor activation, PIPKIg recruits IQGAP1 to the leading edge membrane of migrating cells. Then, PIP 2 generated by PIPKIg interacts with a PBM of IQGAP1 to block the autoinhibitory interaction between the GRD and RGCT domains. The relieved RGCT domain mediates actin polymerization by recruiting N-WASP and the Arp2/3 complex.
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S Choi et al staining with 0.5% crystal violet. Cells were counted in photographs taken from at least five random fields with a Nikon Eclipse TE2000U at Â 200 resolution. Statistical analysis was performed with Microsoft Excel, using data from at least three independent experiments. A Transwell with 3.0 mm pores was used for migration assay and 8.0 mm pores for invasion assay.
Subcellular fractionation assay
Cells were lysed in a hypotonic lysis buffer (Del Pozo et al, 2002) for 10 min. Then cell lysates were homogenized with 15 strokes of a Dounce homogenizer. Homogenates were centrifuged at 700 g for 3 min to pellet nuclei and intact cells. The supernatants were spun at 100 000 g for 30 min at 41C to sediment particulates. The cytosolcontaining supernatant was removed and the crude membrane pellet was gently washed with the lysis buffer. Protein concentration was determined in the membrane and cytosolic fractions. Equal amounts of protein were resolved by SDS-PAGE and further analysed by immunoblotting.
Fluorescence microscopy
Glass coverslips were coated with 10 ng/ml COL, fibronectin, gelatin or 10% serum before seeding cells. For Figure 5 , coverslips were coated as described previously . Cells were grown on coverslips placed inside six-well plates until experimental manipulation. Coverslips were washed twice in 371C PBS, and then fixed with 4% paraformaldehyde, followed by permeabilization with 0.5% Triton X-100 in PBS. The cells were then blocked for 1 h at 251C in 3% BSA. Primary antibody incubation was performed at 41C for 12 h, while incubation with fluorophore-conjugated secondary antibodies occurred at 371C for 45 min. Fluorescence microscopy was performed using a Â 60 planfluor objective on a Nikon Eclipse TE2000U equipped with a Photometrics CoolSNAP ES CCD camera. Images were captured using MetaMorph v6.3 (Molecular Devices). Images were exported to Photoshop CS2 (Adobe) for final processing and assembly.
Liposome sedimentation assay
Liposomes were prepared as previously described (Papayannopoulos et al, 2005) . Dried lipids were resuspended with a buffer containing 150 mM KCl, 50 mM HEPES, pH 7.4, 2 mM MgCl 2 , 2 mM CaCl 2 and 300 mM sucrose. After bath sonication for 20 min, the rehydrated lipids were subjected to at least five cycles of freezing and thawing and extruded through a 0.1 mm filter with a lipid extruder (Avanti). Liposome co-sedimentation assay was performed by mixing 0.5 mM of proteins with 2.5 mM of liposomes in the buffer without sucrose. After 10 min of incubation at 251C, samples were centrifuged at 100 000 g for 30 min at 41C. Pellets were gently washed and resuspended in SDS sample buffer for a final volume equal to the supernatant. Samples were resolved by SDS-PAGE and proteins were detected by either Coomassie staining or immunoblotting.
Live cell imaging
Delta TPG dish (Fisher Scientific) were coated with a gelatin gel as described previously . Cells were seeded at a density of 1.0 Â10 4 cells/dish in L15 culture medium and placed in a temperature-controlled chamber of a Nikon Eclipse TE2000U. Time-lapse recording started 3 h after cell plating. Images were collected every 30 or 60 s for over 5 h with a Photometrics CoolSNAP ES CCD camera (Roper Scientific) operated by Metamorph image analysis software (Molecular Devices). Analyses of collected images including tracking the migration path of individual cells and generation of movies were performed with Metamorph.
Actin polymerization assay
Actin polymerization assay was performed as described before (Le Clainche et al, 2007) . Pyrene-conjugated G-actin (Cytoskeleton) was prepared according to the manufacturer's instructions. Then, 12.5 nM of Arp2/3 complex and 40 nM of N-WASP-DB in the presence of GST-IQGAP1-C (50 nM) and/or 5% phosphoinositideliposomes (2 mM) were incubated for 5 min before the addition of 1.5 mM of pyrene-conjugated G-actin stock. Fluorescence was read immediately after the addition of actin using a PC1 photon counting spectrofluorometer (ISS) set on kinetic mode to read every 20 s for the duration of the assay. PC1 setting was as follows: excitation, 365 nm; emission, 407 mm. Obtained fluorescence density was converted to arbitrary units. The experiments described above were performed independently at least four times. was analyzed by immunoblotting with an anti-IQGAP1 antibody.
Supplementary data
All the experiments described above were performed independently at least three times. 
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All the experiments described above were performed independently at least three times. (D) Actin polymerization was performed in the presence of 50 nM GST-IQGAP1-C with the indicated liposomes.
All the experiments described above were performed independently at least three times.
Supplementary Movie 1. Migration of wild type IQGAP1-reconstituted Iqgap1
-/-
MEFs
Iqgap1 KO MEFs were reconstituted with WT IQGAP1. Then, reconstituted MEFs were plated on gelatin gel for 3 h before recording using time-lapse microscopy. Images were collected every 5 min for 3 h at 400X magnification and combined into a time-lapse movie.
Supplementary Movie 2. Migration of ∆IQ-reconstituted Iqgap1
MEFs
Iqgap1 KO MEFs were reconstituted with the ∆IQ mutant IQGAP1. Then, reconstituted
MEFs were plated on gelatin gel for 3 h before recording using time-lapse microscopy.
Images were collected every 5 min for 3 h at 400X magnification and combined into a time-lapse movie.
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Supplementary Movie 3. Migration of AA3-reconstituted Iqgap1
MEFs
Iqgap1 KO MEFs were reconstituted with the AA3 mutant IQGAP1. Then, reconstituted
Figure S1 LPA  LPC  PI  PI3P  PI4P  PI5P  PE  PC   S1P  PI3,4P 2  PI3,5P 2  PI4,5P This is an interesting, data-rich manuscript reporting a novel interaction between PIPKIg (type I gamma phosphatidylinositol 4-phosphate 5-kinase) and IQGAP1, which is found to be required for persistent cell migration. This IQGAP1/PIPKIg interaction, which involves the IQ domain of IQGAP1, is required for recruitment of IQGAP1 to the cell leading edge, while PI4,5P2 produced by PIPKIg contributes to the opening and activation of IQGAP1 by counteracting an intramolecular interaction of the GRD and RGCT domains in the carboxy-terminal region of IQGAP1. As a consequence, IQGAP1-dependent actin assembly can be restricted spatially ensuring protrusion formation and persistent cell migration. Appropriate controls are provided and data support the main conclusions of the manuscript.
Specific comments 1-Proper quantification of Arp2/3 complex accumulations and the effect of PIPKIg knockdown should be provided (Fig. S1D) . Along the same line, experiments showing rescue of IQGAP1 recruitment to the cell edge by expression of PIPKIgi1 and i2 should be properly quantified (Fig.  3D ). (Fig. 2E ) that optimal serum-induced migration of iqgap-null MEFs can be rescued by IQGAP1 independently of the presence of the IQ domain and thus does not require the interaction of IQGAP1 with PIPKIg seems to contradict data in Fig. 2A -C indicating synergistic functions of the two proteins during serum-induced migration.
2-The finding
3-The authors conclude that PIP2 (produced by PIPKIg) activates IQGAP1-mediated actin assembly. Silencing of PIPKIg interferes with the recruitment of IQGAP1 but also Rac1 recruitment to the leading edge (Fig. 3B) , which is likely to affect cell migration and possibly IQGAP1 recruitment of the leading edge.
Referee #2
This manuscript identifies a new interaction between PIPKIgamma and the IQ domain of the cytoskeletal regulator IQGAP1. Evidence is provided that this interaction is potentiated by appropriate ECM/growth factor stimulation and is important for the localisation of IQGAP1 at the pm, where interaction with the product of PIPKIgamma, PI45P2, 'de-represses' IQGAP1, allowing it to stimulate actin polymerisation.
A lot of technically well executed work is presented. The conceptual novelty is limited; PIPKIgamma, IQGAP1 and PIP2 are known to regulate actin polymerisation at emerging lamellipods, PIP2 has been shown to bind IQGAP1 and the concept that PIPKIs recruit effectors of PIP2 is established. However, this study does bring together several strands of research into a potentially satisfying explanation of the role of PIPKIgamma and IQGAP1 in cell migration.
Specific comments:
1. The data presented in Fig1 showing PIPKIgamma and IQGAP1 interact as endogenous proteins, 'in transfecto' and as recombinant proteins is both compelling and significant. The data presented in Fig 2 suggesting this interaction is important for cell migration is less easy to interpret. The relative effects of PIPKIgamma and IQGAP1 overexpression/knock-down on migration do not directly address this point and, whilst the inability of the 'delta-IQ' mutant to rescue the migration defects of the IQGAP1-KO MEFs provides essential corroborative evidence, it only says that the IQ domain is needed, not that the domain is needed for interaction with PIPKIgamma (the IQ domain is known to interact with other proteins). In this regard, the demonstration that the interaction between PIPKIgamma and IQGAP1 is stimulated by collagen and serum is important ( fig 2D) ; given that the recombinant proteins interact constitutively, do the authors have any evidence as to how this is regulated?
2. The binding of phosphoinositides to IQGAP is obviously complicated, as illustrated by the data presented in this manuscript and in the recent work from the Dundee groups (Dixon et al 2012) . The 'AA3' mutant does however seem to be specifically deficient in its ability to bind PI45P2 (Figs 4F and 6B) . These assays are presented at a single concentration of phosphoinositides, which makes relative comparisons difficult; do the authors have data which illustrates the extent of this specificity? I would also be interested in knowing how PI345P3 behaves in the actin polymerisation assay (Fig 6C) .
Minor points 1. It would be easier for the non-expert if the various isoforms of PIPKIgamma (i1-5) were explained before the discussion. 
Referee #3
The paper by Choi et al. describes the discovery of a novel interaction of the cytoskeletal scaffold protein IQGAP1 and the type Igamma phosphatidylinositol 4-phosphate 5-kinase (PIPKIgamma) with important consequences for motile cell behavior. An affinity approach, using PIPKIgamma as a bait protein, identified IQGAP1 as a potential interacting partner. This interaction was verified using co-immunoprecipitation experiments and also by the use of purified proteins and the IQ-motif of IQGAP1 was mapped as a region required for interaction with PIPKIgamma. Furthermore the authors' show that this interaction is dynamically regulated in response to extracellular signals like serum or adhesion to collagen and seems to work as important signal hub for the regulation of lamellipodia formation and subsequent cellular motility. The authors show that PIPKIgamma is critical for IQGAP1 plasma membrane localization where IQGAP1 binds to PIP2, which relieves the autoinhibitory interaction of the IQGAP1 Gap Related Domain (GRD) and the C-terminus (RGCT). Relieve of this intramolecular interaction through PIP2 binding is proposed to facilitate activation of N-WASP for localized actin polymerization via Arp2/3. This study is overall well conducted and the data provided in this manuscript are definitively very interesting and would be important to publish, but there are significant issues that need to be addressed as outlined below.
The PIP2-mediated activation is an important claim and should be further substantiated by additional controls. The effects on in vitro actin polymerization are rather minor. In this line it would be good to map the interaction interface of PIPKI required to interact with IQGAP1 and test whether this mutant is still able to promote changes in actin dynamics. The authors also propose that PIP2-mediated activation of IQGAP1 promotes interaction with downstream effectors like N-WASP, but data regarding this issue are missing. It would be interesting to see how silencing of PIPKI, mutation of the PIP2 binding motif or the IQ motif affects N-WASP binding in cells.
Another point that puzzles me is the effect of the PIP2-binding deficient mutant on cellular polarity. In principle, the use of IQGAP1 deficient MEFs reconstituted with IQGAP variants is a very elegant approach to address the functional role of specific IQGAP1 regions with regard to cellular motility. I wonder, however, how the PIP2-binding deficient mutant is able to promote multiple lamella formation. Since the authors propose that PIP2-binding may contribute to IQGAP1 activation by opening up the intramolecular GRD/RGCT interaction, which facilitates binding to downstream effector proteins like N-WASP to promote local actin polymerization, the multiple lamella phenotype seems contradictory to me. How is this working? These structures are highly dynamic and depend on actin polymerization. The PIP2-binding deficient mutant of IQGAP1 is clearly enriched in these structures. How does IQGAP1 coordinate actin polymerization in these structures if binding to PIP2 is abolished?
If PIPKI is a critical factor for IQGAP1 localization, does the overexpression of the isolated IQmotif changes the subcellular localization of endogenous IQGAP1?
Data regarding the effect of expression of PH-PLCgamma are contradictory to me. The authors show that endogenous IQGAP1 co-localizes with GFP-PH-PLCgamma at the plasma membrane. In the supplement the authors propose on the basis of fractionation experiments, that expression of PHPLCgamma strips IQGAP1 off the plasma membrane. These fractionation data are not very convincing and miss quantifications and they should be done using membrane flotation assays. Also, the authors claim that PIPKI-binding is more important for localization of IQGAP1 and not PIP2 binding. I suggest clarifying this issue e.g. by titrating the PH-PLC and analyze endogenous IQGAP1 localization under these conditions.
Minor points:
I had problems reading the manuscript, the figure legends should be more informative. E.g. the direct association of IQGAP1 and PIPKI show in figure 1f contains a control blot for GST at the bottom, but it is not clear and not clarified what is shown here.
The immunoblots shown in this work are largely overexposed and it would be more informative to show lower exposures of the films. The input levels for many of the interaction data are missing and should be included.
Would it be possible to provide more informations on the invasion data? It would be interesting to see, how these cells behave, how the cellular morphology is changed in a 3-D matrix after silencing of IQGAP1 or PIPKI. The assay is not well described and it is not clear to me how this was done. Why is there a synergistic effect after silencing of both, IQGAP1 and PIPKI, if the authors postulate a linear signal transduction cascade, starting with the recruitment of IQGAP1 by PIPKI?
The schematic view in figure 7 is, at least to this reviewer, not helpful and I suggest overworking this cartoon. We would like to thank the referees for their invaluable comments and suggestions. Below we detail the changes to the revised manuscript that address the referees' comments followed by the revisions that we have made. (Fig. 3D) .
Intensity of fluorescent signals at the migrating front was measured from at least 10 different images of each condition and quantified using ImageJ software ( Fig. 3D and Fig. S1D ).
The finding (Fig. 2E) Fig. 2A -C indicating synergistic functions of the two proteins during serum-induced migration. We are also intrigued by this result. For Fig. 2A -C, serum-induced migration was measured in MDA-MB-231 and HeLa, whereas, MEFs were used for Fig. 2E . These seemingly contradictory observations could be in part explained by cell type specificity. In other words, in MEFs the ∆IQ mutant could mediate serum-induced cell migration independent of PIPKIγ. In support of this notion, in our previous study , we showed that epidermal growth factor (EGF)-induced cell migration requires PIPKIγ, whereas lysophosphatidic acid (LPA )-induced migration is independent of PIPKIγ. As LPA is one of the most important factors in serum that induces MEF migration (Kim et al, 2008) , it is likely that LPA mediates serum-induced MEF migration of the ∆IQ mutant (Fig. S2D) .
The authors conclude that PIP 2 (produced by PIPKIg) activates IQGAP1-mediated actin assembly. Silencing of PIPKIg interferes with the recruitment of IQGAP1 but also Rac1 recruitment to the leading edge (Fig. 3B), which is likely to affect cell migration and possibly IQGAP1 recruitment of the leading edge.
We totally agree with the referee's comment. Silencing of PIPKIγ blocks IQGAP1 recruitment to the leading edge (Fig. 3B-D and) , which might be indirectly through interference of Rac1 recruitment (Fig. 3B ). This is consistent with previous report that the physical interaction of PIPKIs with Rac1 regulates plasma membrane targeting of Rac1 (Chao et al, 2010) . To test the sole contribution of PIPKIg for IQGAP1 targeting, we utilized a Rac1 binding defective mutant PIPKIg (E111L) (Halstead et al, 2010) . The mutant co-immunoprecipitated with IQGAP1 similar to wild type PIPKIg (Fig. S2E) indicating that Rac1 binding to PIPKIg is not required for the PIPKIg interaction with IQGAP1. Notably, the E111L mutant enhanced IQGAP1 association with the membrane fraction similar to wild type PIPKIg (Fig. S2F ). These data suggest that the IQGAP1 recruitment to the leading edge is largely regulated by PIPKIg independent of Rac1. 
Specific comments:
The data presented in Fig. 1 showing PIPKIg and IQGAP1 interact as endogenous proteins, 'in transfecto' and as recombinant proteins is both compelling and significant. The data presented in Fig. 2 Fig 2D) ; given that the recombinant proteins interact constitutively, do the authors have any evidence as to how this is regulated? Many common signaling pathways are activated in response to serum and collagen stimuli. Among them, PKC is reported to relieve the autoinhibitory fold of IQGAP1, between the N and C termini, by phosphorylation of Ser1441 and Ser1443 upon activation of GPCRs, RTKs or integrins (Brandt & Grosse, 2007) . Because the PIPKIγ binding site within the IQ domain is likely masked by the autoinhibitory fold, Ser1441 and Ser1443 phosphorylation might be required for the PIPKIγ binding. To test this possibility, a phosphorylation defective mutant (S1441A/S1443A) was expressed and the interaction with IQGAP1 was examined by immunoprecipitation. The IQGAP1 interaction with wild type PIPKIg was increased ~4.5 fold in response to serum activation, whereas binding of the phosphorylation defective mutant was not altered (Fig. S2C) . These data indicate that the phosphorylation on Ser1441 and Ser1443 of IQGAP1 is required for the PIPKIg binding in response to membrane receptor activation. PI3, 4, 5P 3 behaves in the actin polymerization assay (Fig. 6C) .
suggesting this interaction is important for cell migration is less easy to interpret. The relative effects of PIPKIg and IQGAP1 overexpression/knock-down on migration do not directly address this point and, whilst the inability of the 'delta-IQ' mutant to rescue the migration defects of the IQGAP1-KO MEFs provides essential corroborative evidence, it only says that the IQ domain is needed, not that the domain is needed for interaction with PIPKIg (the IQ domain is known to interact with other proteins). In this regard, the demonstration that the interaction between PIPKIg and IQGAP1 is stimulated by collagen and serum is important (
The binding experiments between GST-C1 and His-C2 (WT or AA3) were performed with varying concentrations of different liposomes. As shown in Fig. S5C , PI, PI4P and PI3,4,5P 3 had no apparent effect in 0.5 to 8 mM concentration. In contrast, PI4,5P 2 dramatically blocked the C1 and C2 interaction even in the lowest concentration (0.5 mM). Consistent with these binding data, PI4,5P 2 enhanced actin polymerization of IQGAP1-C in a dose dependent manner, whereas PI3,4,5P 3 was much less effective (Fig. S5D ). were explained before the discussion. Information on the various PIPKIγ isoforms is included in the introduction section.
Minor points: It would be easier for the non-expert if the various isoforms of
The legend to Fig 7 needs to explain more clearly what the non-PIPKIg-complexed IQGAP is doing. IQGAP1 that is non-complexed with PIPKIγ may accumulate at cell-cell contacts. We have modified the figure to illustrate this possibility (Fig. 7) . 
Specific comments:
The PIP 2 -mediated activation is an important claim and should be further substantiated by additional controls. Dose dependence experiments were performed using multiple phosphoinositide species to test the specificity of PI4,5P 2 in regulation of the C1 and C2 interaction and actin polymerization. Data presented in Fig. S5C -D indicate that PI4,5P 2 specifically blocks the C1 interaction with C2 and, as a result, enhances actin polymerization activity of IQGAP1.
The effects on in vitro actin polymerization are rather minor. In this line it would be good to map the interaction interface of PIPKIg required to interact with IQGAP1 and test whether this mutant is still able to promote changes in actin dynamics.
We have evidence that both PIPKIa and PIPKIγ interact with IQGAP1 through the IQ domain (Choi et al., manuscript in preparation). PIPKIa and PIPKIγ have high sequence similarity in the kinase domain, whereas they have highly variable N-and C-terimini (Heck et al, 2007) . Thus, it is likely that the IQGAP1 interaction with PIPKIs is mediated by the kinase domain. However, the isolated PIPKI kinase domain is very unstable and truncations or mutations in the kinase domain result in unstable and kinase defective proteins (Coppolino et al, 2002 We tested how mutation of IQGAP1 affects interaction with N-WASP using immunoprecipitation (Fig. S3F) . Wild type IQGAP1 interacts with N-WASP, whereas the PIP 2 -binging defective (AA3) mutant interaction is dramatically reduced. This is consistent with our hypothesis as these data suggest that PIP 2 -binding regulates the recruitment of actin polymerizing machinery to IQGAP1. Intriguingly, the PIPKIg-binding defective (∆IQ) mutant is able to interact with N-WASP. As the N-WASP binding site of the ∆IQ mutant is intact (Fig. 1G) , it is likely that the ∆IQ mutant interacts with the cytosolic pool of N-WASP (Cai et al, 2012; Taunton et al, 2000) . We totally agree with the referee's comment. As PIP 2 -binding of IQGAP1 is critical for N-WASPmediated actin polymerization at the leading edge, we also predicted that a PIP 2 -binding defective mutant might lose its ability to form lamellipodia instead of inducing multiple leading edges. However, this conceptually contradictory observation is not surprising. Previous studies demonstrate that multiple leading edges are induced by perturbation of factors that are important for leading edge formation. For example, Rac1-null neutrophils (Sun et al, 2004) and Cdc42-null dendritic cells (Lammermann et al, 2009 ) form multiple leading edges. Also, FAK knockdown in Rat-2 cells induces multiple leading edges, and migration is retarded in these cells (Tilghman et al, 2005) . Most noteworthy, a previous study (Fukata et al, 2001) reported that an IQGAP1 mutant defective of interaction with Rac1 or Cdc42 induces multiple leading edges in Vero cells. Based on the literature we reason that the PIP 2 -binding defective IQGAP1 mutant, AA3, induces multiple leading edges by loss of its ability to maintain persistent lamellipodium formation. The AA3 mutant targets to the leading edge by interaction with PIPKIγ ( Fig. 5B ) but remains inactive, and that might increase the instability of the lamellipodium as a result of improper actin polymerization (Tilghman et al, 2005) .
Another point that puzzles me is the effect of the PIP
If PIPKIg is a critical factor for IQGAP1 localization, does the overexpression of the isolated IQdomain changes the subcellular localization of endogenous IQGAP1?
The IQ domain was expressed in MDA-MB-231 cells and endogenous IQGAP1 targeting was analyzed by fractionation (Fig. S3E) . Indeed, the isolated IQ domain significantly reduces the association of endogenous IQGAP1 with the membrane fraction. We totally agree with the referee's comment. The PH domain of phospholipase Cδ1 (PLCδ1) has been extensively used to probe cellular PIP 2 (Czech, 2000; Di Paolo & De Camilli, 2006; but excessive expression of PLCd1-PH limits the targeting of PIP 2 binding protein to the plasma membrane . Thus, we initially titrated the PLCd1-PH expression by transfecting with varying amounts of DNA to define an experimental condition for probing PIP 2 or limiting IQGAP1 targeting to the plasma membrane (Fig. S4B) . In the optimal expression condition, endogenous IQGAP1 colocalizes with GFP-PLCd1-PH (white arrowhead). In the excessive expression condition, ~30% of cells seem retracted (yellow arrowhead) and ~20% of cells form lamellipodia that lack IQGAP1 at the periphery (white arrow). We had performed experiments for Fig. 4A and Fig. S3D in the separate conditions (for either probing PiP 2 or limiting IQGAP1 targeting to the plasma membrane) defined.
The data in Fig S3D and Fig. S4B clearly suggest that the PIP 2 -binding also contributes to IQGAP1 targeting to the plasma membrane. However, the data in Fig. S3D and Fig. S4B rely on overexpression of PLCd1-PH that possibly strips off all PIP 2 -binding proteins from the plasma membrane. Because several factors targeting IQGAP1 to the plasma membrane are PIP 2 -binding proteins (Brandt & Grosse, 2007; Fukata et al, 2002; Watanabe et al, 2004) , the data in Fig. S3D and Fig. S4B could be misleading. To better understand the sole contribution of the PIP 2 -binding for IQGAP1 targeting, we expressed a PIP 2 -binding defective mutant (AA3) in Iqgap1 -/-MEFs. The PIP 2 -binding defective mutant still localizes to the plasma membrane, while the PIPKIg-binding defective (∆IQ) mutant is largely cytosolic (Fig. 5B) . These data indicate that the physical interaction between the two proteins is more important than PIP 2 -binding for IQGAP1 plasma membrane targeting.
The currently employed membrane fractionation assay has been used extensively to monitor association of proteins with membrane (Chao et al, 2010; Del Pozo et al, 2002) . We tried to repeat some fractionation experiments with membrane flotation assay. However, it was technically challenging and failed to detect IQGAP1 in our preparation. This could be due to technical errors or IQGAP1 might be hard to float in the assay, similar to other actin or microtubule associated proteins (Schollenberger et al, 2012; Watanabe et al, 2005) .
Minor points:
I had problems reading the manuscript, the figure legends should be more informative. E.g. the direct association of IQGAP1 and PIPKIγ show in Fig. 1F 
contains a control blot for GST at the bottom, but it is not clear and not clarified what is shown here.
We changed the figure legends to be more informative. For Fig. 1F , all our GST-tagged recombinant proteins expressed in bacterial have some degraded products that are detected by immunoblotting with an anti-GST antibody. To overcome this, we also expressed recombinant IQGAP1 proteins using the baculoviral system that produces less degradation product (Fig. S2A) . By both bacterial and baculoviral expression systems, it is shown that the IQ domain alone is sufficient to interact with PIPKIg.
The immunoblots shown in this work are largely overexposed and it would be more informative to show lower exposures of the films. The input levels for many of the interaction data are missing and should be included. We changed immunoblots with lower exposure images if available. Also, we included input levels for the interaction data.
Would it be possible to provide more informations on the invasion data? It would be interesting to see, how these cells behave, how the cellular morphology is changed in a 3-D matrix after silencing of IQGAP1 or PIPKI. Cancer cells extend actin-rich protrusions called invadopodia as they invade into a 3-D matrix and IQGAP1 is required for this process . PIPKIγ localizes at invadopodia and PIPKIγ knockdown significantly reduces invadopodia formation (Choi et al. manuscript preparation). We have not examined morphological changes in a 3-D matrix after manipulation of IQGAP1 or PIPKIg but it would be very interesting to study.
The assay is not well described and it is not clear to me how this was done.
The invasion assay was performed as previously described (Keely, 2001) . Matrigel (BD Bioscience) is a liquid form on ice. Elevating temperature by incubating at 37°C will induce gelling. By doing so, we coated the top part of a Transwell insert (Corning) with 2 mg/ml of low serum Matrigel. Serum induced cell invasion through the gel was measured by placing 10% serum in the lower chamber of a Transwell.
Why is there a synergistic effect after silencing of both, IQGAP1 and PIPKIg, if the authors postulate a linear signal transduction cascade, starting with the recruitment of IQGAP1 by PIPKIg? We totally agree with the referee's comment. Although this study defines how PIPKIg may contribute toward IQGAP1 regulated migration, we do not postulate a linear pathway. As shown in Fig. 2B , overexpression of PIPKIγ or IQGAP1 enhances cell motility, and that is dependent on the expression of the other protein. Additionally, Fig. 2A demonstrates functional synergism of the two proteins in cell motility. The defined mechanism in this study is that PIPKIγ recruits IQGAP1 to the leading edge and activates IQGAP1 by production of PIP 2 , and this seems to support a linear pathway. However, we envision that IQGAP1 might regulate PIPKIg function in cell motility. For example, among the diverse proteins that interact with IQGAP1 are many that can activate PIPKI's kinase activity, such as Arf6 (Hu et al., Cancer Res, 2009 ). Thus, we postulate the association of PIPKIγ with IQGAP1 might enhance PIPKIγ's kinase activity to enhance PIP 2 levels that can both directly regulate IQGAP1 activity, but also stimulate migration, such as by modulating actin regulatory proteins. This is currently under investigation as a part of different project. Figure 7 is, at least to this reviewer, not helpful and I suggest overworking this cartoon. We changed the model to make it more informative (Fig. 7) . I have now received comments from two of the original referees of your manuscript that are both satisfied with the amount of revisions and thus support publication. I would be grateful at this stage if you were to provide original source data, particularly uncropped/-processed electrophoretic blots for the main figures of your manuscript. This is in accord with our policy to make original results better accessible for the community and thus increase reliability of published data. We would welcome one PDF-file per figure for this information. These will be linked online as supplementary "Source Data" files. Please allow me to congratulate you to this study at this point. The editorial office will be in touch soon with an official acceptance letter.
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The revised submission clearly improved a lot and addressed all points to my satisfaction. I therefore recommend publication of the manuscript in its present state.
Referee #3
All our initial concerns have been addressed by the authors.
